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Objectives The purpose of this study was to analyze the electrophysiologic remodeling of the atrophic left ventricle (LV) in
right ventricular (RV) failure (RVF) after RV pressure overload.
Background The LV in pressure-induced RVF develops dysfunction, reduction in mass, and altered gene expression, due to
atrophic remodeling. LV atrophy is associated with electrophysiologic remodeling.
Methods We conducted epicardial mapping in Langendorff-perfused hearts, patch-clamp studies, gene expression studies,
and protein level studies of the LV in rats with pressure-induced RVF (monocrotaline [MCT] injection, n  25;
controls with saline injection, n  18). We also performed epicardial mapping of the LV in patients with RVF af-
ter chronic thromboembolic pulmonary hypertension (CTEPH) (RVF, n  10; no RVF, n  16).
Results The LV of rats with MCT-induced RVF exhibited electrophysiologic remodeling: longer action potentials (APs) at
90% repolarization and effective refractory periods (ERPs) (60  1 ms vs. 44  1 ms; p  0.001), and slower
longitudinal conduction velocity (62  2 cm/s vs. 70  1 cm/s; p  0.003). AP/ERP prolongation agreed with
reduced Kcnip2 expression, which encodes the repolarizing potassium channel subunit KChIP2 (0.07  0.01 vs.
0.11  0.02; p  0.05). Conduction slowing was not explained by impaired impulse formation, as AP maximum
upstroke velocity, whole-cell sodium current magnitude/properties, and mRNA levels of Scn5a were unaltered. In-
stead, impulse transmission in RVF was hampered by reduction in cell length (111.6  0.7 m vs. 122.0  0.4 m;
p  0.02) and width (21.9  0.2 m vs. 25.3  0.3 m; p  0.002), and impaired cell-to-cell impulse transmission
(24% reduction in Connexin-43 levels). The LV of patients with CTEPH with RVF also exhibited ERP prolongation
(306  8 ms vs. 268  5 ms; p  0.001) and conduction slowing (53  3 cm/s vs. 64  3 cm/s; p  0.005).
Conclusions Pressure-induced RVF is associated with electrophysiologic remodeling of the atrophic LV. (J Am Coll Cardiol
2012;59:2193–202) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.063Right ventricular (RV) failure (RVF) secondary to chronic
pressure overload is an important determinant of survival in
patients with chronic thromboembolic pulmonary hyperten-
sion (CTEPH) and other forms of pulmonary arterial
hypertension (PAH) (1,2). These patients develop not only
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accepted January 10, 2012.RV dysfunction, but also left ventricular (LV) dysfunction
(3,4). LV diastolic filling is diminished, because diastolic
LV peak filling rate is related to RV ejection fraction (5).
See page 2203
We recently reported in CTEPH patients with RVF and in
an experimental model of RVF (monocrotaline [MCT]-
induced PAH in rats) that this is associated with a reduction
in LV mass and an altered gene expression profile of the LV,
which is most likely due to atrophic remodeling of the LV
(6). Because unloading and/or atrophy of the LV is associ-
ated with electrophysiologic remodeling (7), we hypothe-
sized that electrophysiologic remodeling of the LV also
occurs in PAH-induced RVF. We therefore studied electro-
physiologic properties and gene expression profiles of the LV
in rats with MCT-induced RVF. Moreover, we investigated
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RVF exhibited similar electro-
physiologic changes in the LV.
Methods
Animal Studies
Investigations conformed with
the Guide for the Care and Use of
Laboratory Animals published by
the U.S. National Institutes of
Health (NIH Publication No.
85-23, revised 1996). Animals
were cared for in accordance with
institutional guidelines for the
care and use of laboratory ani-
mals. Twenty-five 7-week-old
male Wistar rats received an in-
traperitoneal injection of MCT
(60 mg/kg) to induce PAH and
RVF. Eighteen control animals
were injected intraperitoneally
with the same volume of saline (3
ml/kg). As reported previously
(8), MCT injection leads to sub-
sequent disease stages, culminat-
ing in RVF. To recognize when a
rat reached the RVF stage, we
used clinical criteria: body weight
loss and 1 of the following: dyspnea, hypothermia, cya-
nosis, and lethargy. Rats were sacrificed when they devel-
oped RVF (RVF rats) or at the same time after saline
injection (control rats).
Echocardiographic and electrocardiographic analysis.
Echocardiographic and electrocardiographic (ECG) (limb leads)
recordings were made just before sacrifice. Echocardiographic
analysis of the RV and LV was conducted as reported previously
(8,9). LV volumes were estimated on the basis of the short-axis
area–length method (10). Cardiac output was calculated as LV
stroke volume multiplied by heart rate. RR interval and QRS/QT
duration were analyzed in ECG lead II. Because the diagnosis of
RVF was determined on the basis of clinical, rather than echo-
cardiographic criteria, it was not necessary to perform echocardi-
ography in all animals. Accordingly, we conducted echocardiog-
raphy in 20 rats.
Epicardial mapping. Hearts were harvested immediately
fter sacrifice, and perfused according to the Langendorff
echnique at constant pressure (70 cm water) with Tyrode’s
olution (37°C) containing: sodium chloride 130 mM, potas-
ium chloride 5.6 mM, calcium chloride 2.2 mM, magnesium
hloride 0.55 mM, sodium bicarbonate 24.2 mM, and glucose
1.1 mM (pH 7.4 with 95% oxygen and 5% carbon dioxide)
11). Extracellular electrograms of the LV and RV were
ecorded with a 208-point multielectrode array, mounted on
micromanipulator. Electrodes were silver wires of 0.1 mm
Abbreviations
and Acronyms
AP  action potential
BNP  brain-type
natriuretic peptide
CTEPH  chronic
thromboembolic pulmonary
hypertension
Cx-43  Connexin-43
ECG  electrocardiographic
ERP  effective refractory
period
INa  whole-cell sodium
current
Ito  transient outward
potassium current
LV  left ventricle
MCT  monocrotaline
PAH  pulmonary arterial
hypertension
RT-PCR  real-time
polymerase chain reaction
RV  right ventricle
RVF  right ventricular
failure
TAPSE  tricuspid annulus
plane systolic excursioniameter and arranged in a 16 13 grid at 0.5-mm interelec-rode distances. Recordings were made during stimulation
rectangular pulses of 2-ms duration and twice diastolic thresh-
ld) from the center of the grid at a basic cycle length of 200
s. The effective refractory period (ERP) (the coupling inter-
al of the shortest premature stimulus that failed to achieve
ocal capture) was determined for each ventricle separately as
ollows. Every eighth stimulus was followed by 1 premature
timulus. Starting at 180 ms, the coupling interval of the
remature stimulus was reduced in steps of 10 ms until
onduction block. Then, starting from the coupling interval of
he last conducted premature stimulus, the coupling interval of
he premature stimulus was reduced in steps of 1 ms until
RP. We constructed activation maps from activation times
12), and calculated longitudinal and transversal conduction
elocities (11) (Fig. 1). The susceptibility to tachyarrhythmias
as tested as reported previously (13).
yocyte isolation and measurement of cell dimensions.
V and RV myocytes of 7 RVF rats and 4 control rats were
solated enzymatically (14), and the length and width of 50
Figure 1
Method to Determine Effective
Refractory Period and Conduction
Velocity in Rats (Epicardial Mapping: Methods)
(A) Examples of determination of effective refractory period during programmed
stimulation. (B) Examples of subepicardial activation maps during constant pacing
from the center of the multielectrode array at basic cycle length of 200 ms; arrows
indicate direction of longitudinal conduction wavefront (L) and transversal conduc-
tion wavefront (T). CTRL  control; LV  left ventricle; RV  right ventricle; RVF 
right ventricular failure; S1  stimulus applied at basic cycle length of 200 ms;
S  premature stimulus with a coupling interval at the refractory period.2
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sured (3-m resolution).
Cellular electrophysiology. Action potentials (APs) and
whole-cell sodium current (INa) were recorded using stan-
ard methods. Voltage control, data acquisition, and anal-
sis were accomplished using custom-made software. INa
signals were low-pass filtered (cutoff 5 kHz) and digitized at
20 kHz. APs were filtered and digitized at 10 and 40 kHz,
respectively. Cell membrane capacitance (Cm) was estimated
s described previously (15). Series resistance was compensated
o reduce resistance voltage errors and increase the temporal
esolution by 80% in a whole-cell voltage clamp. APs were
ecorded at 36°C  0.2°C with the perforated patch-clamp
technique. INa was recorded at 20°C with the whole-cell
ruptured patch-clamp technique.
Histology. LV and RV tissues were excised from the
positions where the multielectrode recordings were made.
These tissues were obtained from the same positions in all
animals (i.e., the LV and RV free walls). These tissues were
fixed in formalin (RVF rats, n  4 and control rats, n  4).
Seven-micrometer-thick sections were cut parallel to the
epicardium, stained with Picro-sirius Red, and examined by
light microscopy (10 magnification) for collagen. The
amount of collagen in the recording area was determined
using the Image-Pro Plus software package (version 5.02,
Media Cybernetics, Bethesda, Maryland) after digitizing 6
randomly selected fields per section with a slide scanner.
Western blots and immunohistochemistry. Total cellular
protein was isolated from the LV and RV free walls from
the positions where the multielectrode recordings were
made (RVF rats, n  5 and control rats, n  5). Standard
SDS-PAGE and Western blot analyses were conducted
using antibodies directed against the Connexin-43 protein
(Cx-43, Transduction). To compare the expression levels
of Cx-43 between RVF and control hearts, the pooled
samples were separated on gel (25 g total cellular
protein per sample) and blotted onto nitrocellulose. The
optical densities of the obtained signals were quantified
(ImageQuant software, Molecular Dynamics, Sunnyvale,
California) and corrected for possible deviations in the
amount of transferred total protein. For this, reversible
Ponceau-S staining of the blots was performed, after
which signals were digitized by scanning at 400 dpi.
Cryosections (10-m thickness) were sliced perpendicu-
lar to the epicardial surface from biopsies rapidly frozen
in liquid nitrogen. Thus, each section encompassed the
entire ventricular wall. Immunohistochemistry was per-
formed as described previously (13).
Quantitative real-time polymerase chain reaction. RNA
was isolated from LV samples of 4 RVF and 5 control rats
from the positions where the multielectrode recordings were
made. mRNA expression levels of the main subunits of the
cardiac sodium channel (Scn5a), the L-type calcium channel
(Cacna1c), and the various potassium channels (Kcnip2,
Kcnd2, Kcnd3, Kcna4, Kcnq1, Kcne1) were quantified using
the LightCycler system for real-time polymerase chainreaction (RT-PCR) (Roche Applied Science, Basel, Swit-
zerland). Quantitative RT-PCR data were analyzed with
the LinRegPCR program (16). All samples were processed
in triplicate and expression levels were normalized to glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH).
Patient Studies
We studied 26 CTEPH patients who were included in a
previous study from our group (17). For the present study, we
divided them into 2 groups: patients with RVF (n  10) and
patients without RVF (n 16). RVF was defined as tricuspid
annulus plane systolic excursion (TAPSE) 16 mm (18). All
subjects gave written informed consent. Investigations were
approved by the local institutional review board.
Echocardiography. Echocardiographic data of the whole
cohort were presented in a previous study (17). In this study,
we compared the echocardiographic data between RVF and
non-RVF patients.
Epicardial mapping. All patients underwent in situ epi-
cardial mapping of the LV lateral wall during native
circulation at pulmonary endarterectomy (body core tem-
perature 36.0°C to 36.5°C) as described previously (17).
Using a multielectrode grid (144 or 126 electrodes, 1  1-
or 0.4 0.4-mm interelectrode distance, respectively), we deter-
mined LV ERP by programmed electrical stimulation from the
center of the grid, and calculated longitudinal and transversal
conduction velocities from ellipsoid activation patterns.
Statistical analysis. Statistical analysis was performed us-
ing SPSS software (version 16.0.0, SPSS, Inc., Chicago,
Illinois). All data are presented as mean SEM. Groups were
compared using unpaired 2-tailed Student t tests, Mann-
Whitney U nonparametric test, or chi-square test when appro-
priate. A p value0.05 was considered statistically significant.
Results
Animal Studies
Echocardiographic and autopsy findings. RVF occurred
at 26  2 (range, 22 to 30) days after MCT injection.
Table 1 shows echocardiographic and morphometric vari-
ables of control and RVF rats. Compared with control rats,
RVF rats had a significantly thicker RV wall, a dilated RV
with reduced contractility (TAPSE), and an abnormal
echocardiographic pattern of RV diastolic filling (lower
tricuspid E/A ratio). Diastolic filling of the LV was also
altered (reduced mitral E/A ratio and LV end-diastolic
volume). This was associated with significantly diminished
LV stroke volume and cardiac output. These echocardio-
graphic data were in agreement with autopsy findings;
compared with control rats, RVF rats had significantly
reduced body, liver, and LV weights, and increased lung and
RV weights. Moreover, RVF rats had pleural effusion,
whereas control rats did not.
Electrocardiographic and epicardial mapping. RVF rats
(n  6) had significantly longer QRS and QT durations
than control rats (n  4, 34  1 ms vs. 28  1 ms; p 
r
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espectively). RR interval was not significantly different
etween RVF and control rats (196  14 ms vs.154  16
s; p  0.1). LV ERP was significantly longer in RVF rats
than in control rats (Fig. 2A), whereas LV longitudinal
conduction velocity was significantly reduced (Fig. 2B). In
the RV, ERP was also longer in RVF rats than in control
rats (Fig. 2A). In contrast to the reduction in longitudinal
conduction velocity in the LV of RVF rats, longitudinal and
transversal conduction velocities in the RV were higher in
RVF rats than in control rats (Figs. 2B and 2C). Tachyar-
rhythmias were noninducible during programmed electrical
stimulation, neither in RVF rats, nor in control rats.
Cellular electrophysiology. To establish the cellular basis
of ERP prolongation and reduction in longitudinal conduc-
tion velocity, we conducted electrophysiologic studies in
isolated LV and RV myocytes. Figure 3A shows represen-
tative APs from a LV and RV myocyte of a control rat and
a RVF rat. LV and RV myocytes of RVF rats had
significantly longer APs at 90% repolarization at all pacing
rates tested (Figs. 3B and 3C). In contrast, no significant
differences in maximal upstroke velocity were observed
between RVF and control rats. Similarly, no differences in
resting membrane potential or AP amplitude were found
(data not shown). In further support of the notion that
conduction slowing was not explained by changes in ionic
currents, patch-clamp studies of INa revealed that mean INa
densities and voltage dependence of INa steady-state activa-
tion/inactivation in LV myocytes were not different between
Echocardiographic andMorphometric Variables of Rats at SacrificeTable 1 Echo rdiographic andMorphometric Variables of Rats at Sacrifice
Control
(n  18)
RVF
(n  20) p Value
Echocardiographic variables
Right ventricle
Free-wall thickness, mm 0.62 0.01 1.11 0.03 0.001
End-diastolic diameter, mm 4.1 0.1 6.8 0.2 0.001
Tricuspid E/A ratio 0.7 0.1 0.2 0.1 0.001
Tricuspid annulus plane systolic
excursion, mm
3.0 0.2 1.6 0.1 0.001
Left ventricle
Mitral E/A ratio 1.22 0.0 0.85 0.1 0.001
End-diastolic volume, l 379 6 324 7 0.001
End-systolic volume, l 130 4 134 4 0.48
Stroke volume, l 249 5 190 6 0.001
Ejection fraction, % 66 1 59 1 0.001
Cardiac output, ml/min 93 2 54 2 0.001
Morphometric variables
Body weight, g 350 16 284 12 0.001
RV weight 0.23 0.00 0.41 0.01 0.001
LV weight 1.13 0.27 0.95 0.29 0.001
RV weight/LV weight ratio 0.2 0.0 0.4 0.0 0.001
Lung weight, g 1.3 0.1 2.3 0.2 0.001
Liver weight, g 15 1 11 1 0.001
Values are mean  SD.
LV  left ventricular; RV  right ventricular; RVF  right ventricular failure.RVF and control rats (Table 2, Fig. 4). In RV myocytes,V1/2 of activation was 9 mV more negative in RVF than
in control rats (p  0.05), whereas voltage-dependent
inactivation was not different (Table 2, Fig. 4).
Morphometric and tissue properties, protein levels, and
mRNA expression patterns. Given that changes in con-
duction velocity may occur on the basis of altered cell
dimensions (reduced conduction velocity at smaller myocyte
size [15]) and/or changes in cell-to-cell impulse transmis-
sion, we next studied cell dimensions, protein levels of
Cx-43, and tissue properties. LV myocytes were shorter and
Figure 2 Refractory Periods and Conduction Velocities
in Rats (Epicardial Mapping: Results)
(A) Effective refractory period (ERP), (B) longitudinal conduction velocity (CV),
and (C) transversal CV in right ventricle (RV) and left ventricle (LV) of right ven-
tricular failure (RVF) and control (CTRL) rats.narrower in RVF rats than in control rats (111.6  0.7 m
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June 12, 2012:2193–202 LV Electrophysiology in RV Failurevs. 122.0 0.4m ; p 0.02, and 21.9 0.2m vs. 25.3 0.3
m; p  0.002, respectively) (Fig. 3D), although their
membrane capacitances were similar (30 myocytes of RVF
rats, 144  6 pF vs. 35 myocytes of control rats, 143  7 pF;
p  0.9). Compared with control rats, RV myocytes of RVF
rats were wider (27.7 0.5 m vs. 23.1 0.3 m; p  0.015)
nd had larger membrane capacitance (166  9 pF [26
yocytes] vs. 132  6 pF [46 myocytes], p  0.002),
hereas their lengths were not different (108.4 0.9 m vs.
110.9  0.5 m; p  0.9) (Fig. 3D). Figure 5A shows
ouble labeling of Cx-43 and alpha-actinin. Cx-43 expres-
Figure 3 APDs in Rats
(A) Action potential durations (APDs) at 2.5-Hz pacing rate in isolated right ventric
(CTRL) rats. (B) AP duration (APD) at 20%, 50%, and 90% repolarization (APD20, A
Isolated RV and LV myocytes of RVF and CTRL rats.
Sodium Current PropertiesTable 2 Sodium Current Properties
RV LV
Control
(n  10)
RVF
(n  8)
Control
(n  8)
RVF
(n  8)
Current density,
pA/pF
86 11 66 8 76 11 66 10
Inactivation
V1/2, mV 88.1 3.2 95.5 2.7 92.8 3.0 89.6 4.0
k, mV 6.7 0.5 6.9 0.5 6.6 0.6 7.0 0.4
Activation
V1/2, mV 52.0 2.5 60.8 1.8* 58.0 3.0 58.5 2.2
k, mV 4.0 0.3 4.0 0.5 4.6 0.5 4.0 0.5
Values are mean  SD. *p 0.05 versus control.e
k  slope factor of (in)activation; V1/2  half-maximal voltage of (in)activation; other
abbreviations as in Table 1.ion was homogeneous and aligned along the intercalated
isc, and, to a lesser extent, along the lateral myocyte
orders. Cx-43 expression in the LV was less dense in RVF
ats than in control rats, but remained homogeneous. In the
V, Cx-43 expression was denser in RVF rats than in control
ats. Quantification of Cx-43 protein expression by Western
lotting indicated a 24% decrease in the LV and a 30% increase
n the RV of RVF rats (signals were corrected for differences in
he total amount of transferred protein) (Fig. 5B). The amount
f interstitial collagen deposition was increased in the RV, but
ot the LV, of RVF rats compared with controls (Fig. 5C).
Finally, we conducted quantitative PCR analysis in LV
yocytes of the major ion channels that constitute the rat
V AP. This analysis revealed that mRNA expression levels
f Kcnip2 (which encodes KChIP2, an auxiliary subunit of
he transient outward potassium current, Ito) were signifi-
antly reduced in RVF rats, in accordance with the observed
P/ERP prolongation. In contrast, expression of other
otassium, sodium, and calcium channel subunits remained
nchanged (Fig. 5D).
atient Studies
atient characteristics and echocardiographic analysis.
atient characteristics are summarized in Table 3. All patients
sed oral anticoagulants for at least 3 months, 7 used the dual
and left ventricle (LV) myocytes of right ventricular failure (RVF) and control
APD90) at 2.5 Hz. (C) AP duration at 90% repolarization (APD90) at 1 to 8 Hz. (D)le (RV)
PD50,ndothelin receptor antagonist bosentan, and none used anti-
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beta-blockers). There were no significant differences in age
and/or gender between patients without RVF (n  16) and
ith RVF (n  10) (56  4 years vs. 61  3 years; p  0.3;
nd 7 women/9 men vs. 6 women/4 men; p  0.7). No
patient had coronary artery disease at coronary angiography.
Patients with RVF had, on average, longer PQ and QTc
durations, higher mean pulmonary arterial pressure, right
atrial pressure, and pulmonary capillary wedge pressure, as
well as larger total pulmonary resistance. In contrast, they
had smaller RV stroke volume and cardiac output. Echo-
cardiographic findings are summarized in Table 4. Patients
with RVF had larger RV end-diastolic diameter with lower
indexes of early diastolic relaxation (E=) and contractility
(TAPSE). They also had significantly lower LV end-
diastolic diameter and volume, along with lower early LV
diastolic relaxation velocity and LV ejection fraction, and
more prominent leftward shift of the interventricular sep-
tum (LV early diastolic eccentricity index).
Electrocardiographic analysis and epicardial mapping.
Patients with RVF had significantly longer PQ and QTc
duration than patients without RVF (Table 3). LV ERP in
patients with RVF was significantly longer than in patients
without RVF (Figs. 6A and 6B), and longitudinal conduc-
tion velocity was significantly reduced (Figs. 6C and 6D).
Discussion
The atrophic LV of rats with MCT-induced RVF exhibited
evidence of electrophysiologic remodeling (i.e., longer AP/ERP
and slower conduction velocity). AP/ERP prolongation was
consistent with reduced expression ofKcnip2. Conduction slowing
as not explained by impaired impulse formation, as AP maxi-
um upstroke velocity, INa magnitude/properties, and mRNA
Figure 4 Sodium Channel Activation/Inactivation
Properties in Rats (Sodium Channel Properties)
Average activation/inactivation curves of sodium current. Abbreviations as in Figure 1.evels of Scn5a were unaltered. Instead, impulse transmission was Ahampered, both by reduction in cell size and by impaired cell-to-
cell impulse transmission (reduced Cx-43 levels). AP/ERP pro-
longation and conduction slowing of the LV were also found in
CTEPH patients with RVF.
LV function in RVF due to chronic RV pressure overload.
Clinical (3,5,19,20) and experimental (21) studies demon-
strated that diastolic filling of the LV is impaired in chronic
PAH. LV filling rate relates to RV ejection fraction (5).
Accordingly, we found that LV early diastolic relaxation
velocity and LV end-diastolic volume were reduced in
patients with RVF. Similarly, LV diastolic filling was
impaired in RVF rats. Aside from abnormal LV diastolic
filling, LV systolic function (LV stroke volume and ejection
fraction) was affected in CTEPH patients with RVF and in
RVF rats. These findings agree with previous studies that
showed diminished LV contractility in patients with chronic
RV pressure overload (4,20). Moreover, in a previous study
(6), we found that LV mass was reduced in CTEPH
patients with chronic RV failure, but that LV mass normal-
ized after pulmonary endarterectomy. This finding suggests
that reduced LV systolic function in the setting of RV
failure may be due to a secondary adaptation with abnormal
LV underfilling and mechanical unloading.
Possible mechanisms of LV electrophysiologic remodeling
during RVF. The electrophysiologic changes in the LV
during RVF that we observed both in patients and rats
(AP/ERP prolongation and conduction slowing) were sim-
ilar to changes occurring in the LV during LV failure
(22,23). Moreover, a recent study showed that (sub)epicar-
dial LV monophasic APs are prolonged in MCT rats with
RV hypertrophy (24). Various neurohumoral and mechan-
ical factors may affect LV electrophysiology in RVF after
chronic PAH (3,25–27). In the present study, Kcnip2
mRNA expression levels were reduced. This was predicted
to result in Ito reduction, consistent with previous reports
hat linked hypertrophy and/or failure to reduced KChIP2
xpression and Ito density (24,28–30). Although not mea-
sured in this study, elevated angiotensin II levels may cause
both Ito reduction (26,31) and reduction in Cx-43 expres-
ion (32). Similarly, endothelin-1 may play a role, as it
aused AP prolongation in an experimental study (33),
hereas its plasma levels were augmented in CTEPH
atients (25) and MCT-treated rats (34). Alternatively,
nderfilling may impair LV diastolic function in patients
ith CTEPH (3) and MCT-injected rats with RV hyper-
rophy and failure (21). Mechanical unloading reduces cell
imensions (35,36), regardless of enhanced neurohumoral
timulation (35), and results in AP prolongation (7). In our
tudy, length and width of LV myocytes of RVF rats were
maller than those in control rats, and LV weight was
educed, similar to previous studies (27,37,38). Reduced cell
imensions may in part explain the reduction in longitudi-
al conduction velocity (11,39).
ifferences in electrophysiologic remodeling between
he left and right ventricles. We found that changes in
P/ERP during RVF were qualitatively similar in the RV
2199JACC Vol. 59, No. 24, 2012 Hardziyenka et al.
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divergent between the RV and LV. Moreover, AP/ERP
Figure 5 Expression and Distribution of Connexin-43 and Major
Sarcolemmal Ion Channels in Rats (Connexin-43 and
Expression and distribution of Connexin-43 (Cx-43) and interstitial collagen deposition
failure (RVF) and control (CTRL) rats. (A) Immunolabeling of Cx-43 (green, upper pane
(upper panel) and quantified Cx-43 expression in pooled samples (lower panel). (C) P
tent (lower panel). (D) Quantitative real-time polymerase chain reaction results indica
and potassium channel subunits (Kcnip2, Kcnd2, Kcnd3, Kcna4, Kcnq1, Kcne1). GAPprolongation was more prominent in the RV than in theLV. The resulting dispersion in electrophysiologic proper-
ties between the RV and LV could have predisposed to
r Ion Channels)
RNA expression levels in left ventricle (LV) and right ventricle (RV) in right ventricular
double labeling of Cx-43 (green) and -actinin (red, lower panel). (B) Western blot
rius Red staining of collagen (upper panel) and quantified interstitial collagen con-
NA expression levels of sodium channel (Scn5a), L-type calcium channel (Cacna1c),
glyceraldehyde-3-phosphate dehydrogenase.Majo
, and m
l) and
icro-si
ting mR
DH arrhythmias by generating a substrate for reentry. However,
tion; ot
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LV Electrophysiology in RV Failure June 12, 2012:2193–202we failed to induce arrhythmias in RVF rats or control rats.
This may be, in part, due to prolongation of the excitation
wave (the mathematical product of conduction velocity and
ERP) (40) found in the present study (data not shown),
along with the preservation of the homogeneous distribu-
tion of Cx-43.
Study limitations. First, LV myocardial biopsies were not
taken from CTEPH patients to assess cell and/or tissue
morphology and study cellular electrophysiology. Instead,
in-depth analysis of electrophysiologic properties of the LV
Characteristics of Chronic Thromboembolic PulmTable 3 Characteristics of Chronic Thrombo
N
6-min walking distance, m 4
NYHA functional class, I/II/III/IV
Plasma BNP level, pmol/l
Systolic arterial pressure, mm Hg 1
Diastolic arterial pressure, mm Hg
Mean arterial pressure, mm Hg
Electrocardiography
PQ duration, ms 1
QRS duration, ms
QTc duration, ms 4
Right bundle branch block, n
Catheterization
Mean pulmonary arterial pressure, mm Hg
Total pulmonary resistance, dynes/s/cm5 5
RV stroke volume, ml
Right atrial pressure, mm Hg 6
Cardiac output, l/min 5
Pulmonary capillary wedge pressure, mm Hg 8
Values are mean  SEM, n, or median (interquartile range).
BNP  B-type natriuretic peptide; NYHA  New York Heart Associa
Echocardiographic Measurements in ChronicThromboembolic Pulmona y Hypertension PatienTable 4 Echo ardi graphic Measuremen s iThromboembolic Pulmonary Hyperte
Heart rate, beats/min
Right ventricle, diastole
RV early diastolic relaxation velocity (E=), cm/s
RV end-diastolic diameter, mm
Right ventricle, systole
Tricuspid regurgitation grade, 0/I/II/III
Pulmonary artery systolic pressure, mm Hg
Tricuspid annulus plane systolic excursion, mm
Left ventricle, diastole
LV early diastolic eccentricity index
LV early diastolic relaxation velocity (E=), cm/s
LV end-diastolic diameter, mm
LV end-diastolic volume, m
Left ventricle, systole
LV end-systolic volume, ml
Ejection fraction, %
LV stroke volume, mlValues are mean  SD or n.
Abbreviations as in Table 1.was conducted in the MCT rat model of RVF. Second, we
assessed refractoriness and conduction velocities in animals
during Langendorff perfusion. Therefore, we cannot exclude
that acute changes in LV loading conditions influenced the
electrophysiologic properties of the LV due to mechano-
electrical feedback (41). However, we also found ERP
prolongation and LV longitudinal conduction slowing in
CTEPH patients with RVF whose native circulation was
maintained during recording. Moreover, ERP prolongation
and LV conduction slowing during Langendorff perfusion,
ry Hypertension Patientslic Pulmonary Hypertension Patients
(n  16) RVF (n  10) p Value
6 357 33 0.003
/8/1 0/1/5/4 0.052
98 20 0.001
(20) 114 (122)
116 5 0.04
73 2 0.26
87 3 0.10
184 10 0.015
107 6 0.14
457 9 0.001
2 2 1.00
53 3 0.001
6 1,272 135 0.001
43 5 0.001
.7 13.6 2.0 0.004
.3 3.5 0.2 0.001
.3 (n9) 13.7 2.2 (n7) 0.042
her abbreviations as in Table 1.
onic
n Patients
RVF (n  16) RVF (n  10) p Value
78 2 84 5 0.148
6.8 0.6 4.3 0.7 0.016
39 2 50 4 0.001
1/9/6/0 0/0/3/7 0.001
49 5 89 6 0.001
2.8 0.6 12.3 0.8 0.001
.29 0.05 1.76 0.11 0.001
7.9 0.6 5.9 0.5 0.03
40 2 30 2 0.001
08 6 87 6 0.021
40 3 40 5 0.96
63 2 55 3 0.018
68 3 47 4 0.001onaembo
o RVF
98 2
0/7
11 4
5
31 4
77 2
95 3
56 5
95 5
18 5
34 3
36 7
73 4
.1 0
.7 0
.2 1tsn Chr
nsio
No
2
1
1
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June 12, 2012:2193–202 LV Electrophysiology in RV Failureand AP prolongation in isolated myocytes support the
notion that the observed electrophysiologic remodeling is
mainly explained by impact of chronic RV pressure over-
load. This finding is in agreement with a previous study (41)
in a normal canine heart, in which only acute LV volume
loading, but not an acute increase in LV afterload changed
AP duration. Similarly, acute LV volume loading resulted in
conduction slowing in isolated rabbit hearts (41). Another
study limitation was that epicardial mapping in CTEPH
patients was performed under general anesthesia when
the pericardium was open. Although a previous study
showed that pericardium-mediated interventricular inter-
action in patients with CTEPH is negligible because of
pericardial adaptation to slowly progressive pulmonary
hypertension (42), intrapericardial pressures may well
have been increased in the present study, contributing to
LV underfilling. If so, opening of the pericardium might
have led to changes in interventricular interaction that
affected the electrical properties of the LV due to
Figure 6 Refractory Periods and Conduction Velocities in Patie
(A) Examples of determination of effective refractory period (ERP) during programm
failure (RVF) and without RVF. (C) Examples of subepicardial activation maps durin
600 ms; arrows indicate direction of longitudinal conduction wavefront (L) and tra
without RVF. S1: stimulus applied at basic cycle length of 600 ms; S2: prematuremechanoelectrical feedback.Conclusions
Electrophysiologic remodeling occurs in the atrophic LV of
CTEPH patients with RVF and in the MCT rat model of
PAH-induced RVF. This is associated with abnormal LV
diastolic filling.
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APPENDIX
For an expanded Methods section,
please see the online version of this article.
